The global Attention Deficit Hyperactivity Disorder (ADHD) market was valued at US$ 12240 million in 2023 and is anticipated to reach US$ 19380 million by 2030, witnessing a CAGR of 6.7% during the forecast period 2024-2030.

Attention Deficit Hyperactivity Disorder (ADHD) Market

Effective treatment of ADHD. ADHD refers to a group of syndromes that occur in childhood and are characterized by obvious difficulty in concentration, short duration of attention, hyperactivity or impulsivity compared with children of the same age.

There are two main types of drugs used to treat ADHD: stimulants and non-stimulants

The main manufacturers of stimulants are in Europe and America, and the main manufacturers of non-stimulants are in China.

ADHD is mainly used in hospital pharmacies and retail pharmacies. Among them, in 2020, the market share of retail pharmacies accounted for approximately 83%

Takeda has the highest market share in ADHD by major global companies, which is much higher than the market share of other companies, about 21% in 2020.

This report aims to provide a comprehensive presentation of the global market for Attention Deficit Hyperactivity Disorder (ADHD), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Attention Deficit Hyperactivity Disorder (ADHD).

Report Scope

The Attention Deficit Hyperactivity Disorder (ADHD) market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Attention Deficit Hyperactivity Disorder (ADHD) market comprehensively. Regional market sizes, concerning products by Type, by Distribution Channel, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Attention Deficit Hyperactivity Disorder (ADHD) companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Distribution Channel, and by regions.

Market Segmentation

Scope of Attention Deficit Hyperactivity Disorder (ADHD) Market Report

Report Metric	Details
Report Name	Attention Deficit Hyperactivity Disorder (ADHD) Market
Accounted market size in 2023	US$ 12240 million
Forecasted market size in 2030	US$ 19380 million
CAGR	6.7%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	Stimulant Non-stimulant
Segment by Distribution Channel	Hospital Pharmacy Retail Pharmacy
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Takeda, Johnson & Johnson, Novartis, Eli Lilly, Tris Pharma, Neos Therapeutics, Mallinckrodt, Amneal Pharmaceuticals, Noven Pharmaceuticals, Purdue Parma, CTFH
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Distribution Channel, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Attention Deficit Hyperactivity Disorder (ADHD) companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Distribution Channel, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Attention Deficit Hyperactivity Disorder (ADHD) Market growing?

Ans: The Attention Deficit Hyperactivity Disorder (ADHD) Market witnessing a CAGR of 6.7% during the forecast period 2024-2030.

What is the Attention Deficit Hyperactivity Disorder (ADHD) Market size in 2030?

Ans: The Attention Deficit Hyperactivity Disorder (ADHD) Market size in 2030 will be US$ 19380 million.

Who are the main players in the Attention Deficit Hyperactivity Disorder (ADHD) Market report?

Ans: The main players in the Attention Deficit Hyperactivity Disorder (ADHD) Market are Takeda, Johnson & Johnson, Novartis, Eli Lilly, Tris Pharma, Neos Therapeutics, Mallinckrodt, Amneal Pharmaceuticals, Noven Pharmaceuticals, Purdue Parma, CTFH

What are the Type segmentation covered in the Attention Deficit Hyperactivity Disorder (ADHD) Market report?

Ans: The Types covered in the Attention Deficit Hyperactivity Disorder (ADHD) Market report are Stimulant, Non-stimulant

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Attention Deficit Hyperactivity Disorder (ADHD) Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Stimulant

1.2.3 Non-stimulant

1.3 Market by Distribution Channel

1.3.1 Global Attention Deficit Hyperactivity Disorder (ADHD) Market Growth by Distribution Channel: 2019 VS 2023 VS 2030

1.3.2 Hospital Pharmacy

1.3.3 Retail Pharmacy

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Attention Deficit Hyperactivity Disorder (ADHD) Market Perspective (2019-2030)

2.2 Attention Deficit Hyperactivity Disorder (ADHD) Growth Trends by Region

2.2.1 Global Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Attention Deficit Hyperactivity Disorder (ADHD) Historic Market Size by Region (2019-2024)

2.2.3 Attention Deficit Hyperactivity Disorder (ADHD) Forecasted Market Size by Region (2025-2030)

2.3 Attention Deficit Hyperactivity Disorder (ADHD) Market Dynamics

2.3.1 Attention Deficit Hyperactivity Disorder (ADHD) Industry Trends

2.3.2 Attention Deficit Hyperactivity Disorder (ADHD) Market Drivers

2.3.3 Attention Deficit Hyperactivity Disorder (ADHD) Market Challenges

2.3.4 Attention Deficit Hyperactivity Disorder (ADHD) Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Attention Deficit Hyperactivity Disorder (ADHD) Players by Revenue

3.1.1 Global Top Attention Deficit Hyperactivity Disorder (ADHD) Players by Revenue (2019-2024)

3.1.2 Global Attention Deficit Hyperactivity Disorder (ADHD) Revenue Market Share by Players (2019-2024)

3.2 Global Attention Deficit Hyperactivity Disorder (ADHD) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Attention Deficit Hyperactivity Disorder (ADHD) Revenue

3.4 Global Attention Deficit Hyperactivity Disorder (ADHD) Market Concentration Ratio

3.4.1 Global Attention Deficit Hyperactivity Disorder (ADHD) Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Attention Deficit Hyperactivity Disorder (ADHD) Revenue in 2023

3.5 Attention Deficit Hyperactivity Disorder (ADHD) Key Players Head office and Area Served

3.6 Key Players Attention Deficit Hyperactivity Disorder (ADHD) Product Solution and Service

3.7 Date of Enter into Attention Deficit Hyperactivity Disorder (ADHD) Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Attention Deficit Hyperactivity Disorder (ADHD) Breakdown Data by Type

4.1 Global Attention Deficit Hyperactivity Disorder (ADHD) Historic Market Size by Type (2019-2024)

4.2 Global Attention Deficit Hyperactivity Disorder (ADHD) Forecasted Market Size by Type (2025-2030)

5 Attention Deficit Hyperactivity Disorder (ADHD) Breakdown Data by Distribution Channel

5.1 Global Attention Deficit Hyperactivity Disorder (ADHD) Historic Market Size by Distribution Channel (2019-2024)

5.2 Global Attention Deficit Hyperactivity Disorder (ADHD) Forecasted Market Size by Distribution Channel (2025-2030)

6 North America

6.1 North America Attention Deficit Hyperactivity Disorder (ADHD) Market Size (2019-2030)

6.2 North America Attention Deficit Hyperactivity Disorder (ADHD) Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Country (2019-2024)

6.4 North America Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Attention Deficit Hyperactivity Disorder (ADHD) Market Size (2019-2030)

7.2 Europe Attention Deficit Hyperactivity Disorder (ADHD) Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Country (2019-2024)

7.4 Europe Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Attention Deficit Hyperactivity Disorder (ADHD) Market Size (2019-2030)

8.2 Asia-Pacific Attention Deficit Hyperactivity Disorder (ADHD) Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Region (2019-2024)

8.4 Asia-Pacific Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Attention Deficit Hyperactivity Disorder (ADHD) Market Size (2019-2030)

9.2 Latin America Attention Deficit Hyperactivity Disorder (ADHD) Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Country (2019-2024)

9.4 Latin America Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Attention Deficit Hyperactivity Disorder (ADHD) Market Size (2019-2030)

10.2 Middle East & Africa Attention Deficit Hyperactivity Disorder (ADHD) Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Country (2019-2024)

10.4 Middle East & Africa Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Takeda

11.1.1 Takeda Company Detail

11.1.2 Takeda Business Overview

11.1.3 Takeda Attention Deficit Hyperactivity Disorder (ADHD) Introduction

11.1.4 Takeda Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2019-2024)

11.1.5 Takeda Recent Development

11.2 Johnson & Johnson

11.2.1 Johnson & Johnson Company Detail

11.2.2 Johnson & Johnson Business Overview

11.2.3 Johnson & Johnson Attention Deficit Hyperactivity Disorder (ADHD) Introduction

11.2.4 Johnson & Johnson Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2019-2024)

11.2.5 Johnson & Johnson Recent Development

11.3 Novartis

11.3.1 Novartis Company Detail

11.3.2 Novartis Business Overview

11.3.3 Novartis Attention Deficit Hyperactivity Disorder (ADHD) Introduction

11.3.4 Novartis Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2019-2024)

11.3.5 Novartis Recent Development

11.4 Eli Lilly

11.4.1 Eli Lilly Company Detail

11.4.2 Eli Lilly Business Overview

11.4.3 Eli Lilly Attention Deficit Hyperactivity Disorder (ADHD) Introduction

11.4.4 Eli Lilly Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2019-2024)

11.4.5 Eli Lilly Recent Development

11.5 Tris Pharma

11.5.1 Tris Pharma Company Detail

11.5.2 Tris Pharma Business Overview

11.5.3 Tris Pharma Attention Deficit Hyperactivity Disorder (ADHD) Introduction

11.5.4 Tris Pharma Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2019-2024)

11.5.5 Tris Pharma Recent Development

11.6 Neos Therapeutics

11.6.1 Neos Therapeutics Company Detail

11.6.2 Neos Therapeutics Business Overview

11.6.3 Neos Therapeutics Attention Deficit Hyperactivity Disorder (ADHD) Introduction

11.6.4 Neos Therapeutics Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2019-2024)

11.6.5 Neos Therapeutics Recent Development

11.7 Mallinckrodt

11.7.1 Mallinckrodt Company Detail

11.7.2 Mallinckrodt Business Overview

11.7.3 Mallinckrodt Attention Deficit Hyperactivity Disorder (ADHD) Introduction

11.7.4 Mallinckrodt Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2019-2024)

11.7.5 Mallinckrodt Recent Development

11.8 Amneal Pharmaceuticals

11.8.1 Amneal Pharmaceuticals Company Detail

11.8.2 Amneal Pharmaceuticals Business Overview

11.8.3 Amneal Pharmaceuticals Attention Deficit Hyperactivity Disorder (ADHD) Introduction

11.8.4 Amneal Pharmaceuticals Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2019-2024)

11.8.5 Amneal Pharmaceuticals Recent Development

11.9 Noven Pharmaceuticals

11.9.1 Noven Pharmaceuticals Company Detail

11.9.2 Noven Pharmaceuticals Business Overview

11.9.3 Noven Pharmaceuticals Attention Deficit Hyperactivity Disorder (ADHD) Introduction

11.9.4 Noven Pharmaceuticals Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2019-2024)

11.9.5 Noven Pharmaceuticals Recent Development

11.10 Purdue Parma

11.10.1 Purdue Parma Company Detail

11.10.2 Purdue Parma Business Overview

11.10.3 Purdue Parma Attention Deficit Hyperactivity Disorder (ADHD) Introduction

11.10.4 Purdue Parma Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2019-2024)

11.10.5 Purdue Parma Recent Development

11.11 CTFH

11.11.1 CTFH Company Detail

11.11.2 CTFH Business Overview

11.11.3 CTFH Attention Deficit Hyperactivity Disorder (ADHD) Introduction

11.11.4 CTFH Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2019-2024)

11.11.5 CTFH Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Amneal Pharmaceuticals

Noven Pharmaceuticals

Purdue Parma

CTFH

List of Tables

Table 1. Global Attention Deficit Hyperactivity Disorder (ADHD) Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Stimulant

Table 3. Key Players of Non-stimulant

Table 4. Global Attention Deficit Hyperactivity Disorder (ADHD) Market Size Growth by Distribution Channel (US$ Million): 2019 VS 2023 VS 2030

Table 5. Global Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Region (2019-2024) & (US$ Million)

Table 7. Global Attention Deficit Hyperactivity Disorder (ADHD) Market Share by Region (2019-2024)

Table 8. Global Attention Deficit Hyperactivity Disorder (ADHD) Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 9. Global Attention Deficit Hyperactivity Disorder (ADHD) Market Share by Region (2025-2030)

Table 10. Attention Deficit Hyperactivity Disorder (ADHD) Market Trends

Table 11. Attention Deficit Hyperactivity Disorder (ADHD) Market Drivers

Table 12. Attention Deficit Hyperactivity Disorder (ADHD) Market Challenges

Table 13. Attention Deficit Hyperactivity Disorder (ADHD) Market Restraints

Table 14. Global Attention Deficit Hyperactivity Disorder (ADHD) Revenue by Players (2019-2024) & (US$ Million)

Table 15. Global Attention Deficit Hyperactivity Disorder (ADHD) Market Share by Players (2019-2024)

Table 16. Global Top Attention Deficit Hyperactivity Disorder (ADHD) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Attention Deficit Hyperactivity Disorder (ADHD) as of 2023)

Table 17. Ranking of Global Top Attention Deficit Hyperactivity Disorder (ADHD) Companies by Revenue (US$ Million) in 2023

Table 18. Global 5 Largest Players Market Share by Attention Deficit Hyperactivity Disorder (ADHD) Revenue (CR5 and HHI) & (2019-2024)

Table 19. Key Players Headquarters and Area Served

Table 20. Key Players Attention Deficit Hyperactivity Disorder (ADHD) Product Solution and Service

Table 21. Date of Enter into Attention Deficit Hyperactivity Disorder (ADHD) Market

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Type (2019-2024) & (US$ Million)

Table 24. Global Attention Deficit Hyperactivity Disorder (ADHD) Revenue Market Share by Type (2019-2024)

Table 25. Global Attention Deficit Hyperactivity Disorder (ADHD) Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 26. Global Attention Deficit Hyperactivity Disorder (ADHD) Revenue Market Share by Type (2025-2030)

Table 27. Global Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Distribution Channel (2019-2024) & (US$ Million)

Table 28. Global Attention Deficit Hyperactivity Disorder (ADHD) Revenue Market Share by Distribution Channel (2019-2024)

Table 29. Global Attention Deficit Hyperactivity Disorder (ADHD) Forecasted Market Size by Distribution Channel (2025-2030) & (US$ Million)

Table 30. Global Attention Deficit Hyperactivity Disorder (ADHD) Revenue Market Share by Distribution Channel (2025-2030)

Table 31. North America Attention Deficit Hyperactivity Disorder (ADHD) Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 32. North America Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Country (2019-2024) & (US$ Million)

Table 33. North America Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Country (2025-2030) & (US$ Million)

Table 34. Europe Attention Deficit Hyperactivity Disorder (ADHD) Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 35. Europe Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Country (2019-2024) & (US$ Million)

Table 36. Europe Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Country (2025-2030) & (US$ Million)

Table 37. Asia-Pacific Attention Deficit Hyperactivity Disorder (ADHD) Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 38. Asia-Pacific Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Region (2019-2024) & (US$ Million)

Table 39. Asia-Pacific Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Region (2025-2030) & (US$ Million)

Table 40. Latin America Attention Deficit Hyperactivity Disorder (ADHD) Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 41. Latin America Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Country (2019-2024) & (US$ Million)

Table 42. Latin America Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Country (2025-2030) & (US$ Million)

Table 43. Middle East & Africa Attention Deficit Hyperactivity Disorder (ADHD) Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 44. Middle East & Africa Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Country (2019-2024) & (US$ Million)

Table 45. Middle East & Africa Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Country (2025-2030) & (US$ Million)

Table 46. Takeda Company Detail

Table 47. Takeda Business Overview

Table 48. Takeda Attention Deficit Hyperactivity Disorder (ADHD) Product

Table 49. Takeda Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2019-2024) & (US$ Million)

Table 50. Takeda Recent Development

Table 51. Johnson & Johnson Company Detail

Table 52. Johnson & Johnson Business Overview

Table 53. Johnson & Johnson Attention Deficit Hyperactivity Disorder (ADHD) Product

Table 54. Johnson & Johnson Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2019-2024) & (US$ Million)

Table 55. Johnson & Johnson Recent Development

Table 56. Novartis Company Detail

Table 57. Novartis Business Overview

Table 58. Novartis Attention Deficit Hyperactivity Disorder (ADHD) Product

Table 59. Novartis Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2019-2024) & (US$ Million)

Table 60. Novartis Recent Development

Table 61. Eli Lilly Company Detail

Table 62. Eli Lilly Business Overview

Table 63. Eli Lilly Attention Deficit Hyperactivity Disorder (ADHD) Product

Table 64. Eli Lilly Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2019-2024) & (US$ Million)

Table 65. Eli Lilly Recent Development

Table 66. Tris Pharma Company Detail

Table 67. Tris Pharma Business Overview

Table 68. Tris Pharma Attention Deficit Hyperactivity Disorder (ADHD) Product

Table 69. Tris Pharma Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2019-2024) & (US$ Million)

Table 70. Tris Pharma Recent Development

Table 71. Neos Therapeutics Company Detail

Table 72. Neos Therapeutics Business Overview

Table 73. Neos Therapeutics Attention Deficit Hyperactivity Disorder (ADHD) Product

Table 74. Neos Therapeutics Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2019-2024) & (US$ Million)

Table 75. Neos Therapeutics Recent Development

Table 76. Mallinckrodt Company Detail

Table 77. Mallinckrodt Business Overview

Table 78. Mallinckrodt Attention Deficit Hyperactivity Disorder (ADHD) Product

Table 79. Mallinckrodt Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2019-2024) & (US$ Million)

Table 80. Mallinckrodt Recent Development

Table 81. Amneal Pharmaceuticals Company Detail

Table 82. Amneal Pharmaceuticals Business Overview

Table 83. Amneal Pharmaceuticals Attention Deficit Hyperactivity Disorder (ADHD) Product

Table 84. Amneal Pharmaceuticals Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2019-2024) & (US$ Million)

Table 85. Amneal Pharmaceuticals Recent Development

Table 86. Noven Pharmaceuticals Company Detail

Table 87. Noven Pharmaceuticals Business Overview

Table 88. Noven Pharmaceuticals Attention Deficit Hyperactivity Disorder (ADHD) Product

Table 89. Noven Pharmaceuticals Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2019-2024) & (US$ Million)

Table 90. Noven Pharmaceuticals Recent Development

Table 91. Purdue Parma Company Detail

Table 92. Purdue Parma Business Overview

Table 93. Purdue Parma Attention Deficit Hyperactivity Disorder (ADHD) Product

Table 94. Purdue Parma Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2019-2024) & (US$ Million)

Table 95. Purdue Parma Recent Development

Table 96. CTFH Company Detail

Table 97. CTFH Business Overview

Table 98. CTFH Attention Deficit Hyperactivity Disorder (ADHD) Product

Table 99. CTFH Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2019-2024) & (US$ Million)

Table 100. CTFH Recent Development

Table 101. Research Programs/Design for This Report

Table 102. Key Data Information from Secondary Sources

Table 103. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Attention Deficit Hyperactivity Disorder (ADHD) Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Attention Deficit Hyperactivity Disorder (ADHD) Market Share by Type: 2023 VS 2030

Figure 3. Stimulant Features

Figure 4. Non-stimulant Features

Figure 5. Global Attention Deficit Hyperactivity Disorder (ADHD) Market Size Comparison by Distribution Channel (2024-2030) & (US$ Million)

Figure 6. Global Attention Deficit Hyperactivity Disorder (ADHD) Market Share by Distribution Channel: 2023 VS 2030

Figure 7. Hospital Pharmacy Case Studies

Figure 8. Retail Pharmacy Case Studies

Figure 9. Attention Deficit Hyperactivity Disorder (ADHD) Report Years Considered

Figure 10. Global Attention Deficit Hyperactivity Disorder (ADHD) Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 11. Global Attention Deficit Hyperactivity Disorder (ADHD) Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 12. Global Attention Deficit Hyperactivity Disorder (ADHD) Market Share by Region: 2023 VS 2030

Figure 13. Global Attention Deficit Hyperactivity Disorder (ADHD) Market Share by Players in 2023

Figure 14. Global Top Attention Deficit Hyperactivity Disorder (ADHD) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Attention Deficit Hyperactivity Disorder (ADHD) as of 2023)

Figure 15. The Top 10 and 5 Players Market Share by Attention Deficit Hyperactivity Disorder (ADHD) Revenue in 2023

Figure 16. North America Attention Deficit Hyperactivity Disorder (ADHD) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 17. North America Attention Deficit Hyperactivity Disorder (ADHD) Market Share by Country (2019-2030)

Figure 18. United States Attention Deficit Hyperactivity Disorder (ADHD) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 19. Canada Attention Deficit Hyperactivity Disorder (ADHD) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 20. Europe Attention Deficit Hyperactivity Disorder (ADHD) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. Europe Attention Deficit Hyperactivity Disorder (ADHD) Market Share by Country (2019-2030)

Figure 22. Germany Attention Deficit Hyperactivity Disorder (ADHD) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. France Attention Deficit Hyperactivity Disorder (ADHD) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. U.K. Attention Deficit Hyperactivity Disorder (ADHD) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. Italy Attention Deficit Hyperactivity Disorder (ADHD) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. Russia Attention Deficit Hyperactivity Disorder (ADHD) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. Nordic Countries Attention Deficit Hyperactivity Disorder (ADHD) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Asia-Pacific Attention Deficit Hyperactivity Disorder (ADHD) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Asia-Pacific Attention Deficit Hyperactivity Disorder (ADHD) Market Share by Region (2019-2030)

Figure 30. China Attention Deficit Hyperactivity Disorder (ADHD) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Japan Attention Deficit Hyperactivity Disorder (ADHD) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. South Korea Attention Deficit Hyperactivity Disorder (ADHD) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Southeast Asia Attention Deficit Hyperactivity Disorder (ADHD) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. India Attention Deficit Hyperactivity Disorder (ADHD) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Australia Attention Deficit Hyperactivity Disorder (ADHD) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Latin America Attention Deficit Hyperactivity Disorder (ADHD) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Latin America Attention Deficit Hyperactivity Disorder (ADHD) Market Share by Country (2019-2030)

Figure 38. Mexico Attention Deficit Hyperactivity Disorder (ADHD) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Brazil Attention Deficit Hyperactivity Disorder (ADHD) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Middle East & Africa Attention Deficit Hyperactivity Disorder (ADHD) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Middle East & Africa Attention Deficit Hyperactivity Disorder (ADHD) Market Share by Country (2019-2030)

Figure 42. Turkey Attention Deficit Hyperactivity Disorder (ADHD) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Saudi Arabia Attention Deficit Hyperactivity Disorder (ADHD) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Takeda Revenue Growth Rate in Attention Deficit Hyperactivity Disorder (ADHD) Business (2019-2024)

Figure 45. Johnson & Johnson Revenue Growth Rate in Attention Deficit Hyperactivity Disorder (ADHD) Business (2019-2024)

Figure 46. Novartis Revenue Growth Rate in Attention Deficit Hyperactivity Disorder (ADHD) Business (2019-2024)

Figure 47. Eli Lilly Revenue Growth Rate in Attention Deficit Hyperactivity Disorder (ADHD) Business (2019-2024)

Figure 48. Tris Pharma Revenue Growth Rate in Attention Deficit Hyperactivity Disorder (ADHD) Business (2019-2024)

Figure 49. Neos Therapeutics Revenue Growth Rate in Attention Deficit Hyperactivity Disorder (ADHD) Business (2019-2024)

Figure 50. Mallinckrodt Revenue Growth Rate in Attention Deficit Hyperactivity Disorder (ADHD) Business (2019-2024)

Figure 51. Amneal Pharmaceuticals Revenue Growth Rate in Attention Deficit Hyperactivity Disorder (ADHD) Business (2019-2024)

Figure 52. Noven Pharmaceuticals Revenue Growth Rate in Attention Deficit Hyperactivity Disorder (ADHD) Business (2019-2024)

Figure 53. Purdue Parma Revenue Growth Rate in Attention Deficit Hyperactivity Disorder (ADHD) Business (2019-2024)

Figure 54. CTFH Revenue Growth Rate in Attention Deficit Hyperactivity Disorder (ADHD) Business (2019-2024)

Figure 55. Bottom-up and Top-down Approaches for This Report

Figure 56. Data Triangulation

Figure 57. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Cerebral Palsy Treatment Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-36K2790

Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global Chorea Treatment Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-22U5801

Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global Autism Diagnostic Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-29P12566

Mon Mar 25 00:00:00 UTC 2024

Add to Cart

Spinal Cord Stimulation Devices - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-11Z11048

Thu Mar 21 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions